Literature DB >> 8864205

Expression and characterisation of the NS1 and NS2 proteins of respiratory syncytial virus.

J E Evans1, P A Cane, C R Pringle.   

Abstract

The NS1 and NS2 proteins of human respiratory syncytial virus (RSV) were expressed using baculovirus. Antisera to these expressed proteins and to synthetic peptides were raised in rabbits and used to characterise the proteins. Multiple forms of both NS1 and NS2 proteins were detected in RSV infected cells by both immunoblotting and radioimmunoprecipitation when non-reducing, but not reducing, conditions were used. In pulse-labelling experiments the monomeric form of NS1 was stable, while that of NS2 was unstable with a half life of about 30 min. The NS1 protein associated with the matrix (M) protein and could be co-precipitated by a monoclonal antibody to M protein. The NS2 protein did not show any detectable association with RSV structural proteins. These results indicate that the NS1 and NS2 proteins have distinct roles in the viral life cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864205     DOI: 10.1016/0168-1702(96)01327-5

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology.

Authors:  Weining Wu; Kim C Tran; Michael N Teng; Kate J Heesom; David A Matthews; John N Barr; Julian A Hiscox
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.

Authors:  Joanne Elliott; Oonagh T Lynch; Yvonne Suessmuth; Ping Qian; Caroline R Boyd; James F Burrows; Richard Buick; Nigel J Stevenson; Olivier Touzelet; Massimo Gadina; Ultan F Power; James A Johnston
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response.

Authors:  J Schlender; B Bossert; U Buchholz; K K Conzelmann
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location.

Authors:  Samer Swedan; Joel Andrews; Tanmay Majumdar; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 5.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways.

Authors:  Samer Swedan; Alla Musiyenko; Sailen Barik
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3.

Authors:  Birgit Bossert; Sabrina Marozin; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 10.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.